CRISPR-Cas9 protein (NLS)
-
- Antigène
- CRISPR-Cas9
- Type de proteíne
- Recombinant
- Origine
- Streptococcus aureus
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- NLS
- Application
- Genome Editing with Engineered Nucleases (GEEN)
- Fonction
- SaCas9 2NLS Nuclease
- Attributs du produit
- Recombinant Streptococcus aureus tag-free Cas9 nuclease expressed in an Escherichia coli with both N-terminal and C-terminal nucleic localization signal (NLS).
- Purification
- Escherichia coli expression system
- niveau d'endotoxine
- 10 EU/mg as analyzed by gel clotting method
-
-
- Indications d'application
-
CRISPR Genomic editing
The optimal working dilution should be determined by the end user. - Procédure de l'essai
-
Cleavage assay: A 20 uL reaction in 1xSaCas9 Nuclease Reaction Buffer containing linearized plasmid, gRNA, and SaCas9 2NLS Nuclease for 2 hours at 37°C results in a digestion efficiency of linearized plasmid higher than 90%, as determined by agarose gel electrophoresis.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In 20 mM Tris, 300 mM NaCl, 0.1 mM TCEP, pH 7.5 (50 % glycerol).
- Stock
- -20 °C
-
- Antigène
- CRISPR-Cas9
- Autre désignation
- Cas9 nuclease
-